pRC/CMV-TYK2V678F-VSV
(Plasmid
#139349)
-
PurposeExpression of a gain of function TYK2-V678F protein (correspoding to JAK2-V617F)
-
Depositing Lab
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 139349 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonepRC/CMV
-
Vector typeMammalian Expression
-
Selectable markersNeomycin (select with G418)
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)DH5alpha
-
Copy numberHigh Copy
Gene/Insert
-
Gene/Insert nameTYK2 cDNA with 267nt of 5' UTR
-
SpeciesH. sapiens (human)
-
MutationV362F-V678F
-
Entrez GeneTYK2 (a.k.a. IMD35, JTK1)
- Promoter CMV
-
Tag
/ Fusion Protein
- VSV (C terminal on insert)
Cloning Information
- Cloning method Restriction Enzyme
- 5′ cloning site BspEI (not destroyed)
- 3′ cloning site BstXI (not destroyed)
- 5′ sequencing primer T7
- 3′ sequencing primer Sp6 (Common Sequencing Primers)
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
pRC/CMV-TYK2V678F-VSV was a gift from Sandra Pellegrini (Addgene plasmid # 139349 ; http://n2t.net/addgene:139349 ; RRID:Addgene_139349) -
For your References section:
The Stat3-activating Tyk2 V678F mutant does not up-regulate signaling through the type I interferon receptor but confers ligand hypersensitivity to a homodimeric receptor. Gakovic M, Ragimbeau J, Francois V, Constantinescu SN, Pellegrini S. J Biol Chem. 2008 Jul 4;283(27):18522-9. doi: 10.1074/jbc.M801427200. Epub 2008 May 2. 10.1074/jbc.M801427200 PubMed 18456658